Sedation rates may vary among countries, depending on patients' and endoscopists' preferences.
Professor Spiros Ladas and colleagues from Greece investigated the rate of using premedication for routine diagnostic upper gastrointestinal endoscopy.
The research team evaluated the rates from endoscopy societies, and members of the European Society of Gastrointestinal Endoscopy.
The researchers assessed a multiple-choice questionnaire which was e-mailed to 45 representatives of national endoscopy societies.
|Less than 25% of patients had the procedure with conscious sedation|
The national endoscopy societies are members of the European Society of Gastrointestinal Endoscopy.
The questionnaire had 14 items referring to endoscopy practices in each country, and the representatives' endoscopy units.
The researchers reported that the response rate was 76%.
In 47% of the countries, less than 25% of patients underwent routine diagnostic upper gastrointestinal endoscopy with conscious sedation.
The team observed that in 62% of the responders' endoscopy units, patients are not asked their preference for sedation and do not sign a consent form.
The research team noted that common sedatives in use were midazolam, diazepam or propofol.
The team found that monitoring equipment is not available in most of the endoscopy units' in 46% of the countries.
Monitoring equipment were available in 91% of the national representatives' endoscopy units.
However, the team noted that the monitoring equipment are rarely used to monitor unsedated routine diagnostic upper gastrointestinal endoscopy.
Professor Ladas' team commented, “In about 50% of European Society of Gastrointestinal Endoscopy-related countries, less than 25% of patients are sedated for routine diagnostic upper gastrointestinal endoscopy.”
“Major issues to improve include the availability of monitoring equipment, and the use of a consent form.”